Safety Study of Electrocardiogram (ECG) Effects of Sancuso® (Granisetron TDS)

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

This study aims to evaluate the electrocardiogram (ECG) effects of Sancuso® compared to placebo and moxifloxacin in healthy subjects.

Key facts

Study ID
NCT00890565
Run by
Kyowa Kirin Co., Ltd.
People needed
240
Starts
2009-05-01
Expected to finish
2009-09-01
Last updated by the study team
2024-06-17

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.